share_log

Needham Reiterates Buy on Cidara Therapeutics, Maintains $3 Price Target

Needham Reiterates Buy on Cidara Therapeutics, Maintains $3 Price Target

Needham 重申买入 Cidara Therapeutics,维持3美元的目标股价
Benzinga ·  2023/09/08 04:17

Needham analyst Joseph Stringer reiterates Cidara Therapeutics (NASDAQ:CDTX) with a Buy and maintains $3 price target.

Needham分析师约瑟夫·斯金格重申了Cidara Therapeutics(纳斯达克股票代码:CDTX)的买入,并维持3美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发